Delivery Order SPE2DB24D1034-SPE2DB24FWAZ2

Award Date 7/10/24
Potential Completion Date 7/11/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,030.84 firm fixed price delivery order is for the supply of WIXELA 250-50 INHUB 60S, a pharmaceutical product. The award is not associated with a set-aside program. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,175.16 Firm Fixed Price Delivery Order is for the supply of WIXELA 250-50 INHUB 60S, a medical product, with a period of performance through January 7, 2025. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,286.24 firm fixed-price delivery order is for the provision of WIXELA 250-50 INHUB 60S medical products. The contract has an ultimate completion date of November 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,060.22 firm fixed-price delivery order is for the supply of WIXELA 250-50 INHUB 60S, a medical product, with a performance period ending on April 30, 2025. The contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,053.24 firm fixed-price delivery order is for the supply of WIXELA 250-50 INHUB 60S, a pharmaceutical product. The contract has an ultimate completion date of November 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The federal contract award, identified as SPE2DB20D3101|SPE2DB25FRAW7, was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,498.06 Firm Fixed Price Delivery Order contract is for the supply of WIXELA 250-50 INHUB 60S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $1,456.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WIXELA 500-50 INHUB 60S, a pharmaceutical product. The award is a Firm Fixed Price Delivery Order with a period of performance through November 5, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,478.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of WIXELA 250-50 INHUB 60S, a pharmaceutical product. The award was made as a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for DLA to...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,519.44 for the supply of WIXELA 250-50 INHUB 60S medical devices. The award was issued by the Defense Logistics Agency (DLA), which supports the medical needs of the U.S. military and other federal agencies. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, with a potential value of...
This federal contract award, valued at $1,143.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WIXELA 250-50 INHUB 60S, a pharmaceutical product, and has an ultimate completion date of January 17, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. AmerisourceBergen holds a...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB24FWAZ2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $1,907.77 firm-fixed-price delivery order is for the supply of WIXELA 250-50 INHUB 60S, a respiratory medication.

The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

In addition to the DLA IDC, AmerisourceBergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. As a leading pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to efficiently fulfill government contracts for critical medical commodities.

Generated 10/9/24, 9:21 AM